Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Innoviva Inc
(NQ:
INVA
)
15.20
-0.17 (-1.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
428,631
Open
15.53
Bid (Size)
14.53 (1)
Ask (Size)
15.72 (1)
Prev. Close
15.37
Today's Range
15.13 - 15.63
52wk Range
11.40 - 16.86
Shares Outstanding
65,504,384
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
April 24, 2024
From
Innoviva Specialty Therapeutics
Via
Business Wire
5 Value Stocks In The Healthcare Sector
March 04, 2024
Via
Benzinga
Performance
YTD
-7.15%
-7.15%
1 Month
+2.63%
+2.63%
3 Month
-4.40%
-4.40%
6 Month
+11.52%
+11.52%
1 Year
+30.58%
+30.58%
More News
Read More
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
February 29, 2024
From
Innoviva, Inc.
Via
Business Wire
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
January 10, 2024
Via
InvestorPlace
A Look Into Healthcare Sector Value Stocks
May 15, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
May 08, 2023
Via
Benzinga
FDA's AdComm Panel Favors Innoviva's Drug For Multidrug-Resistant Bacterial Infections
April 18, 2023
Via
Benzinga
Chart Of The Day: Innoviva - Individual Investor Favorite
January 08, 2024
Via
Talk Markets
Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 01, 2023
From
Innoviva, Inc.
Via
Business Wire
Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea
November 01, 2023
From
Innoviva Specialty Therapeutics
Via
Business Wire
A Look Into Healthcare Sector Value Stocks
October 02, 2023
Via
Benzinga
Innoviva to Participate in the Cantor Global Healthcare Conference
September 19, 2023
From
Innoviva, Inc.
Via
Business Wire
XACDURO®, The First and Only Antibiotic Developed to Target Acinetobacter, Now Available to Treat Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP) in Adults
September 18, 2023
From
Innoviva, Inc.
Via
Business Wire
Innoviva Appoints Stephen Basso as Chief Financial Officer
August 25, 2023
From
Innoviva, Inc.
Via
Business Wire
Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
August 02, 2023
From
Innoviva, Inc.
Via
Business Wire
Overview Of Value Stocks In The Healthcare Sector
July 31, 2023
Via
Benzinga
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
July 11, 2023
Via
InvestorPlace
Innoviva to Participate in the Goldman Sachs Annual Global Healthcare Conference
June 06, 2023
From
Innoviva, Inc.
Via
Business Wire
AstraZeneca-Spin Off Entasis Secures FDA Approval For First Pathogen-Targeted Therapy Addressing Acinetobacter
May 24, 2023
Via
Benzinga
Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO® (sulbactam for injection; durlobactam for injection), Co-packaged for Intravenous Use
May 23, 2023
From
Innoviva, Inc.
Via
Business Wire
Over $125M Bet On Occidental Petroleum? Check Out These 4 Stocks Insiders Are Buying
May 16, 2023
Via
Benzinga
Results from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published in The Lancet Infectious Diseases
May 11, 2023
From
Innoviva, Inc.
Via
Business Wire
Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
May 09, 2023
From
Innoviva, Inc.
Via
Business Wire
Innoviva Announces Retirement of Board Chairman
April 28, 2023
From
Innoviva, Inc.
Via
Business Wire
Elon Musk Says US Intel Agencies Had Access To Twitter DMs, Alibaba's Ant IPO Might Actually See Light, Airbus Pushes Some 2024 Deliveries: Today's Top Stories
April 18, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.